EGFR and neoplasm: Although our results may suggest that the combined inhibitory targeting of multiple downstream reactions in the EGFR signaling pathway could be an effective means of halting EGFR signaling in tumour cells, utilizing these sites as an actual drug target would be a daunting challenge due to lack of specificity, since these reactions appear in many important cellular processes.